Agcbio
Seattle, US · 1 known investors
AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
Founders & leadership
AS
Alberto SantagostinoChief Executive Officer and President
KM
Kasper MøllerChief Technical Officer and Executive Vice President, Europe & Japan Regions
CW
Christoph WinterhalterChief Business Officer
YT
Yuichiro TashiroinExecutive Vice President, Corporate Functions
CM
Carrie MygattExecutive Vice President, Finance
LA
Luca AlbericiExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility
KY
Kohei YokoyamaExecutive Vice President, Region Japan Facilitator
MA
Motoi AokiHead of Global Quality
Investors · 1
Frequently asked questions
- What does Agcbio do?
- AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
- Who are Agcbio's investors?
- Agcbio's investors include European Equity Partners.
- Where is Agcbio headquartered?
- Agcbio is headquartered in Seattle, US.